Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Mersana Therapeutics, Inc. (MRSN)

5   0.09 (1.83%) 06-26 19:03
Open: 5 Pre. Close: 4.91
High: 5.245 Low: 4.85
Volume: 5,259,222 Market Cap: 485(M)
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen development candidate. It has a strategic research and development partnerships with Merck KGaA and Asana BioSciences, LLC for the development of ADC product candidates utilizing Fleximer. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.25 - 5.26 5.26 - 5.28
Low: 4.8 - 4.82 4.82 - 4.84
Close: 4.96 - 5 5 - 5.02

Technical analysis

as of: 2022-06-24 4:41:44 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 6.12     One year: 7.15
Support: Support1: 3.8    Support2: 2.91
Resistance: Resistance1: 5.24    Resistance2: 6.12
Pivot: 3.71
Moving Average: MA(5): 4.46     MA(20): 3.6
MA(100): 3.88     MA(250): 7
MACD: MACD(12,26): 0.2     Signal(9): 0
Stochastic oscillator: %K(14,3): 94.5     %D(3): 96.1
RSI: RSI(14): 75.2
52-week: High: 14.8  Low: 2.68
Average Vol(K): 3-Month: 1,540 (K)  10-Days: 2,177 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ MRSN ] has closed above the upper band by 0.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 137.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.

Headline News

Sat, 25 Jun 2022
Mersana Therapeutics to Present at Upcoming Investor Conferences -

Fri, 17 Jun 2022
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Short Interest Up 26.5% in May - Defense World

Fri, 10 Jun 2022
Analysts Expect Mersana Therapeutics, Inc. (NASDAQ:MRSN) to Post -$0.53 Earnings Per Share - MarketBeat

Sat, 04 Jun 2022
2022-06-03 | NDAQ:MRSN | Press Release | Mersana Therapeutics Inc. - Stockhouse

Mon, 23 May 2022
Where Will Mersana Therapeutics Inc (MRSN) Stock Go Next After It Has Gained 7.69% in a Week? - InvestorsObserver

Thu, 19 May 2022
Health Care Sector Update for 05/19/2022: SIGA, MRSN, NNOX, XLV, IBB - Nasdaq

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 72 (M)
% Held by Insiders 6.938e+007 (%)
% Held by Institutions 1.1 (%)
Shares Short 3,580 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -1.68e+008
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -392
Return on Assets (ttm) 693
Return on Equity (ttm) -44.1
Qtrly Rev. Growth 43000
Gross Profit (p.s.) 0
Sales Per Share -40.18
EBITDA (p.s.) -5.45331e+007
Qtrly Earnings Growth -2.2
Operating Cash Flow 0 (M)
Levered Free Cash Flow -140 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.13
Price to Cash Flow 5.6

Stock Dividends

Dividend 0
Forward Dividend 4.28e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.